158 related articles for article (PubMed ID: 20670954)
21. Impaired T-cell development in the absence of Vav1 and Itk.
Raberger J; Boucheron N; Sakaguchi S; Penninger JM; Ellmeier W
Eur J Immunol; 2008 Dec; 38(12):3530-42. PubMed ID: 19009524
[TBL] [Abstract][Full Text] [Related]
22. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
23. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
[TBL] [Abstract][Full Text] [Related]
24. Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.
Huang ZY; Barreda DR; Worth RG; Indik ZK; Kim MK; Chien P; Schreiber AD
J Leukoc Biol; 2006 Dec; 80(6):1553-62. PubMed ID: 16921024
[TBL] [Abstract][Full Text] [Related]
25. A role for the Tec family kinase ITK in regulating SEB-induced interleukin-2 production in vivo via c-jun phosphorylation.
Ragin MJ; Hu J; Henderson AJ; August A
BMC Immunol; 2005 Jul; 6():19. PubMed ID: 16042784
[TBL] [Abstract][Full Text] [Related]
26. ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases.
Mortarino M; Gelain ME; Gioia G; Ciusani E; Bazzocchi C; Comazzi S
Vet Immunol Immunopathol; 2009 Apr; 128(4):395-401. PubMed ID: 19144411
[TBL] [Abstract][Full Text] [Related]
27. Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression.
Chu DH; van Oers NS; Malissen M; Harris J; Elder M; Weiss A
J Immunol; 1999 Sep; 163(5):2610-20. PubMed ID: 10453000
[TBL] [Abstract][Full Text] [Related]
28. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
29. Identification of BCAR-1 as a new substrate of Syk tyrosine kinase through a determination of amino acid sequence preferences surrounding the substrate tyrosine residue.
Kim JY; Huh K; Jung R; Kim TJ
Immunol Lett; 2011 Mar; 135(1-2):151-7. PubMed ID: 21047529
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
31. [Effect of dendritic cells pulsed with Talpha146-162 on autoimmune myasthenia graves and the role of B cells activation].
Wang R; Yang H; Xiao B; Zhang LF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):793-7. PubMed ID: 19950585
[TBL] [Abstract][Full Text] [Related]
32. Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses.
Brühl H; Cihak J; Goebel N; Talke Y; Renner K; Hermann F; Rodriguez-Gomez M; Reich B; Plachý J; Stangassinger M; Mack M
J Leukoc Biol; 2014 Jul; 96(1):65-72. PubMed ID: 24555985
[TBL] [Abstract][Full Text] [Related]
33. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.
Peters AM; Kohfink B; Martin H; Griesinger F; Wörmann B; Gahr M; Roesler J
Exp Hematol; 1999 May; 27(5):868-74. PubMed ID: 10340403
[TBL] [Abstract][Full Text] [Related]
34. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models.
Cornejo MG; Kharas MG; Werneck MB; Le Bras S; Moore SA; Ball B; Beylot-Barry M; Rodig SJ; Aster JC; Lee BH; Cantor H; Merlio JP; Gilliland DG; Mercher T
Blood; 2009 Mar; 113(12):2746-54. PubMed ID: 19139084
[TBL] [Abstract][Full Text] [Related]
35. Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases.
Ghosh D; Tsokos GC
Autoimmunity; 2010 Feb; 43(1):48-55. PubMed ID: 20001666
[TBL] [Abstract][Full Text] [Related]
36. Inducible expression of hyperactive Syk in B cells activates Blimp-1-dependent terminal differentiation.
Hug E; Hobeika E; Reth M; Jumaa H
Oncogene; 2014 Jul; 33(28):3730-41. PubMed ID: 23955076
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.
Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A
J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201
[TBL] [Abstract][Full Text] [Related]
38. [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice].
Merz H; Lange K; Nadrowitz R; Uckert W; Blankenstein T; Feller AC
Verh Dtsch Ges Pathol; 2003; 87():224-31. PubMed ID: 16888916
[TBL] [Abstract][Full Text] [Related]
39. Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes.
Jiang Y; Cheng H
Leuk Res; 2007 Apr; 31(4):541-5. PubMed ID: 16938345
[TBL] [Abstract][Full Text] [Related]
40. [Effects of Bufalin on SYK and CBL family proteins in induction of HL-60 cell apoptosis].
Qu XJ; Zhao MF; Liu YP; Teng YE; Qu JL; Zhang Y; Xu L; Li YC; Hou KZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):65-8. PubMed ID: 19236749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
